Proteomic Profiling Identifies Distinct Regulation of Proteins in Obese Diabetic Patients Treated with Metformin

Background: Obesity and type 2 diabetes mellitus (T2DM) are characterized by underlying low-grade chronic inflammation. Metformin has been used as the first line of therapy in T2DM as it decreases hepatic glucose production and glucose intestinal absorption, enhances insulin sensitivity and weight l...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshahrani, Awad, Aljada, Ahmad, Masood, Afshan, Mujammami, Muhammad, Alfadda, Assim A., Musambil, Mohthash, Alanazi, Ibrahim O., Al Dubayee, Mohammed, Abdel Rahman, Anas M., Benabdelkamel, Hicham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609691/
https://www.ncbi.nlm.nih.gov/pubmed/37895816
http://dx.doi.org/10.3390/ph16101345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609691/
https://www.ncbi.nlm.nih.gov/pubmed/37895816
http://dx.doi.org/10.3390/ph16101345

Ejemplares similares